Centocor Shareholders Set To Vote On J&J Acquisition Offer Oct. 6
This article was originally published in The Gray Sheet
Executive Summary
Centocor shareholders will meet Oct. 6 to vote on a proposal by Johnson & Johnson to purchase the biotechnology company in a stock swap valued at over $5 bil., according to an "S-4" merger prospectus filed with the Securities & Exchange Commission Sept. 7.